With the arrival of summer in our country and vaccination COVID-19Although the effect of ‘ has decreased, the pandemic continues in various countries. Health companies have also accelerated their vaccine studies. Pfizer and BioNTech became one of the prominent companies in this process. The two companies have now submitted their COVID-19 vaccine for children to the approval of the US Food and Drug Administration.
Pfizer and BioNTech await approval for pediatric vaccine!
Pfizer and BioNTechA three-dose for children 6 months to 4 years old COVID-19 vaccine resubmitted its application to the FDA. Both companies applied to the FDA for emergency use approval of the vaccine in February. At that time, the companies’ applications were rejected due to the need for more data. If this time new COVID-19 vaccine approved by the FDA for investigation.
Coronavirus warning from the USA!
While the normalization process continues in many parts of the world, the USA made important warnings about the coronavirus.
Pfizer 3 doses of the vaccine in the trials last week in children under 5 years old He explained that he created a strong immunity. In the next process FDA will also decide whether to grant emergency use authorization by investigating the dangers of the vaccine and its effect against COVID-19.
FDA also last week for children 6 months and older. Moderna vaccines announced that it will discuss the request for an emergency use permit. FDA’s Vaccines and Related Biologicals Advisory Committee for this request. on June 15 will be collected. Moderna applied for this vaccine at the end of April.
of Moderna children under 5 years old The vaccine contains one quarter of the adult dose. The vaccine developed by Moderna for children consists of two doses of 25 micrograms. This dose is stated to be a quarter of that of adults. Pfizer and BioNTechThe vaccine has 3 doses of 3 micrograms. This is equivalent to 1/10 the adult dose.
New for kids under five COVID-19 vaccine Making a statement about its initiatives, the FDA used the following statements:
We know that parents are concerned about getting their young children vaccinated against COVID-19. As the FDA, we cannot predict how long it will take to evaluate data and information, but we will review any emergency use approval request we receive as soon as possible with a science-based approach.
The FDA has yet to give a clear response to the requests. Vaccines are primarily FDAThey will be reviewed by the relevant sections of . and their usability will be discussed. After FDA approval new childhood vaccines Centers for Disease Control and Prevention (CDC) will be submitted for acceptance.
After various tests to be made, the approval process of the vaccines will begin. So what do you think about the COVID-19 vaccine for children under 5 years old? You can share your views with us in the comments section.